Tella has enhanced the efficiency and increased the usage of dendritic cell vaccination therapy. Our therapeutic methods were developed and studied at the Institute of Medical Science, The University of Tokyo, and have founded numerous positive effects with few side effects. It is our mission to further improve methods and technology to make this therapy more useful to a larger number of cancer patients, supporting clinics, hospitals and medical institutes that wish to incorporate this therapy.